Heather Ledbetter Prichard is Chief Operating Officer of Humacyte, Inc.. Currently has a direct ownership of 0 shares of HUMA, which is worth approximately $0. The most recent transaction as insider was on May 31, 2024, when has been sold 2,625 shares (Common Stock) at a price of $9.41 per share, resulting in proceeds of $24,701. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Heather Ledbetter Prichard Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 31 2024
SELL
Open market or private sale
$24,701 $9.41 p/Share
2,625 Reduced 100.0%
0 Common Stock
May 30 2024
SELL
Open market or private sale
$1,535,643 $8.13 p/Share
188,886 Reduced 98.63%
2,625 Common Stock
May 30 2024
BUY
Exercise of conversion of derivative security
$357,984 $2.82 p/Share
126,945 Added 71.42%
50,791 Common Stock
May 25 2023
SELL
Open market or private sale
$36,817 $3.83 p/Share
9,613 Reduced 12.96%
64,566 Common Stock
May 25 2023
BUY
Exercise of conversion of derivative security
$77,338 $1.19 p/Share
64,990 Added 46.7%
74,179 Common Stock
May 24 2023
SELL
Open market or private sale
$57,086 $4.14 p/Share
13,789 Reduced 60.01%
9,189 Common Stock
May 24 2023
BUY
Exercise of conversion of derivative security
$16,408 $1.19 p/Share
13,789 Added 37.5%
22,978 Common Stock
Dec 12 2022
BUY
Exercise of conversion of derivative security
$7,548 $1.15 p/Share
6,564 Added 41.67%
9,189 Common Stock
Aug 26 2021
BUY
Grant, award, or other acquisition
-
2,625 Added 50.0%
2,625 Common Stock
HLP

Heather Ledbetter Prichard

Chief Operating Officer
Durham, NC

Track Institutional and Insider Activities on HUMA

Follow Humacyte, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HUMA shares.

Notify only if

Insider Trading

Get notified when an Humacyte, Inc. insider buys or sells HUMA shares.

Notify only if

News

Receive news related to Humacyte, Inc.

Track Activities on HUMA